FDA Clears Profound Medical's AI Model for Treating Prostate Cancer | Knobbe Martens
Profound Medical (Nasdaq: PROF) has received FDA 510(k) clearance for its second AI model aimed at treating prostate cancer. Profound Medical is a Toronto-based company, which...